|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-2-26
|
|
pubmed:abstractText |
Increased parathyroid activity associated with chronic kidney disease is often managed with calcitriol, which can elevate serum calcium (Ca) by increasing bone resorption and intestinal absorption, whereas paricalcitol promotes less bone resorption. This study compared intestinal Ca absorption in hemodialysis patients treated with calcitriol versus paricalcitol (dose ratio 1:3).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9670
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2009 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
165-70
|
|
pubmed:meshHeading |
pubmed-meshheading:20016142-Adult,
pubmed-meshheading:20016142-Calcitriol,
pubmed-meshheading:20016142-Calcium,
pubmed-meshheading:20016142-Cross-Over Studies,
pubmed-meshheading:20016142-Ergocalciferols,
pubmed-meshheading:20016142-Female,
pubmed-meshheading:20016142-Humans,
pubmed-meshheading:20016142-Intestines,
pubmed-meshheading:20016142-Kidney Failure, Chronic,
pubmed-meshheading:20016142-Male,
pubmed-meshheading:20016142-Middle Aged,
pubmed-meshheading:20016142-Parathyroid Hormone,
pubmed-meshheading:20016142-Phosphorus,
pubmed-meshheading:20016142-Renal Dialysis,
pubmed-meshheading:20016142-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patients.
|
|
pubmed:affiliation |
Department of Medicine, Creighton University, 3316 Dodge Street, Omaha, NE 68154, USA. RLund@creighton.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
